Total planned funding: $248,127,833
Allocations
Countries/Regions
Eswatini | $248,127,833 |
Organizational Types
Private Contractor | $62,230,423 |
University | $56,136,610 |
NGO | $50,791,091 |
Own Agency | $31,198,871 |
Unknown | $26,181,828 |
Host Country Government Agency | $11,123,308 |
FBO | $6,188,454 |
Other USG Agency | $2,183,408 |
Multi-lateral Agency | $1,503,840 |
Implementing Agency | $590,000 |
Program Areas
Care | $79,409,120 |
Treatment | $48,174,407 |
Prevention | $46,025,289 |
Governance and Systems | $33,450,790 |
Testing | $20,748,423 |
Management and Operations | $20,319,804 |
Budget Codes
HTXS: Treatment: Adult Treatment | $38,505,760 |
HBHC: Care: Adult Care and Support | $36,024,707 |
HKID: Care: Orphans and Vulnerable Children | $22,230,895 |
HVCT: Testing: HIV Testing and Counseling | $20,748,423 |
HVMS: Management and Operations | $20,319,804 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,347,912 |
HVTB: Care: TB/HIV | $14,879,773 |
HVSI: Strategic Information | $13,769,665 |
OHSS: Health Systems Strengthening | $13,642,919 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,668,867 |
HVOP: Sexual Prevention: Other Sexual Prevention | $9,440,618 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,377,892 |
PDCS: Care: Pediatric Care and Support | $6,273,745 |
HLAB: Laboratory Infrastructure | $6,038,206 |
PDTX: Treatment: Pediatric Treatment | $4,927,028 |
HTXD: Treatment: ARV Drugs | $4,741,619 |
HMBL: Biomedical Prevention: Blood Safety | $1,190,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Columbia University:
$49,124,075
Countries/Regions
Pact, Inc.:
$30,037,534
Countries/Regions
Not Available:
$21,632,842
Countries/Regions
USG Aggregated Agencies:
$14,983,192
Countries/Regions